Beijing Health Guard

Beijing Health Guard is a clinical-stage biotechnology company based in China, specializing in the development of recombinant protein vaccines. The company's primary focus is on its Human Papillomavirus (HPV) vaccine pipeline, which includes trivalent, nine-valent, and fifteen-valent candidates currently in late-stage clinical trials. Beyond HPV, Beijing Health Guard is expanding its portfolio to include vaccines for respiratory syncytial virus (RSV), shingles, and norovirus. The company utilizes a proprietary virus-like particle (VLP) technology platform to design highly immunogenic and stable vaccine candidates. Beijing Health Guard is publicly traded on the Beijing Stock Exchange and aims to address significant unmet medical needs in infectious disease prevention globally.